Flavonoids-Rich Orthosiphon stamineus Extract as New Candidate for Angiotensin I-Converting Enzyme Inhibition: A Molecular Docking Study

This study aims to evaluate the in vitro angiotensin-converting enzyme (ACE) inhibition activity of different extracts of Orthosiphon stamineus (OS) leaves and their main flavonoids, namely rosmarinic acid (RA), sinensetin (SIN), eupatorin (EUP) and 3′-hydroxy-5,6,7,4′-tetramethoxyflavone (TMF). Fur...

Full description

Bibliographic Details
Main Authors: Armaghan Shafaei, Md Shamsuddin Sultan Khan, Abdalrahim F. A. Aisha, Amin Malik Shah Abdul Majid, Mohammad Razak Hamdan, Mohd Nizam Mordi, Zhari Ismail
Format: Article
Language:English
Published: MDPI AG 2016-11-01
Series:Molecules
Subjects:
Online Access:http://www.mdpi.com/1420-3049/21/11/1500
id doaj-5840f5571327418c8b2a7a0f5f1d2fbd
record_format Article
spelling doaj-5840f5571327418c8b2a7a0f5f1d2fbd2020-11-24T22:28:10ZengMDPI AGMolecules1420-30492016-11-012111150010.3390/molecules21111500molecules21111500Flavonoids-Rich Orthosiphon stamineus Extract as New Candidate for Angiotensin I-Converting Enzyme Inhibition: A Molecular Docking StudyArmaghan Shafaei0Md Shamsuddin Sultan Khan1Abdalrahim F. A. Aisha2Amin Malik Shah Abdul Majid3Mohammad Razak Hamdan4Mohd Nizam Mordi5Zhari Ismail6Department of Pharmaceutical Chemistry, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Minden, Penang 11800, MalaysiaEMAN Testing & Research Laboratory, Department of Pharmacology, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Minden, Penang 11800, MalaysiaDepartment of Pharmaceutical Chemistry, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Minden, Penang 11800, MalaysiaEMAN Testing & Research Laboratory, Department of Pharmacology, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Minden, Penang 11800, MalaysiaCentre for Drug Research, Universiti Sains Malaysia, Minden, Penang 11800, MalaysiaCentre for Drug Research, Universiti Sains Malaysia, Minden, Penang 11800, MalaysiaDepartment of Pharmaceutical Chemistry, School of Pharmaceutical Sciences, Universiti Sains Malaysia, Minden, Penang 11800, MalaysiaThis study aims to evaluate the in vitro angiotensin-converting enzyme (ACE) inhibition activity of different extracts of Orthosiphon stamineus (OS) leaves and their main flavonoids, namely rosmarinic acid (RA), sinensetin (SIN), eupatorin (EUP) and 3′-hydroxy-5,6,7,4′-tetramethoxyflavone (TMF). Furthermore, to identify possible mechanisms of action based on structure–activity relationships and molecular docking. The in vitro ACE inhibition activity relied on determining hippuric acid (HA) formation from ACE-specific substrate (hippuryl-histidyl-leucine (HHL)) by the action of ACE enzyme. A High Performance Liquid Chromatography method combined with UV detection was developed and validated for measurement the concentration of produced HA. The chelation ability of OS extract and its reference compounds was evaluated by tetramethylmurexide reagent. Furthermore, molecular docking study was performed by LeadIT-FlexX: BioSolveIT’s LeadIT program. OS ethanolic extract (OS-E) exhibited highest inhibition and lowest IC50 value (45.77 ± 1.17 µg/mL) against ACE compared to the other extracts. Among the tested reference compounds, EUP with IC50 15.35 ± 4.49 µg/mL had highest inhibition against ACE and binding ability with Zn (II) (56.03% ± 1.26%) compared to RA, TMF and SIN. Molecular docking studies also confirmed that flavonoids inhibit ACE via interaction with the zinc ion and this interaction is stabilized by other interactions with amino acids in the active site. In this study, we have demonstrated that changes in flavonoids active core affect their capacity to inhibit ACE. Moreover, we showed that ACE inhibition activity of flavonoids compounds is directly related to their ability to bind with zinc ion in the active site of ACE enzyme. It was also revealed that OS extract contained high amount of flavonoids other than RA, TMF, SIN and EUP. As such, application of OS extract is useful as inhibitors of ACE.http://www.mdpi.com/1420-3049/21/11/1500angiotensin-converting enzymehypertensionflavonoidsHPLC-UVmolecular ducking study
collection DOAJ
language English
format Article
sources DOAJ
author Armaghan Shafaei
Md Shamsuddin Sultan Khan
Abdalrahim F. A. Aisha
Amin Malik Shah Abdul Majid
Mohammad Razak Hamdan
Mohd Nizam Mordi
Zhari Ismail
spellingShingle Armaghan Shafaei
Md Shamsuddin Sultan Khan
Abdalrahim F. A. Aisha
Amin Malik Shah Abdul Majid
Mohammad Razak Hamdan
Mohd Nizam Mordi
Zhari Ismail
Flavonoids-Rich Orthosiphon stamineus Extract as New Candidate for Angiotensin I-Converting Enzyme Inhibition: A Molecular Docking Study
Molecules
angiotensin-converting enzyme
hypertension
flavonoids
HPLC-UV
molecular ducking study
author_facet Armaghan Shafaei
Md Shamsuddin Sultan Khan
Abdalrahim F. A. Aisha
Amin Malik Shah Abdul Majid
Mohammad Razak Hamdan
Mohd Nizam Mordi
Zhari Ismail
author_sort Armaghan Shafaei
title Flavonoids-Rich Orthosiphon stamineus Extract as New Candidate for Angiotensin I-Converting Enzyme Inhibition: A Molecular Docking Study
title_short Flavonoids-Rich Orthosiphon stamineus Extract as New Candidate for Angiotensin I-Converting Enzyme Inhibition: A Molecular Docking Study
title_full Flavonoids-Rich Orthosiphon stamineus Extract as New Candidate for Angiotensin I-Converting Enzyme Inhibition: A Molecular Docking Study
title_fullStr Flavonoids-Rich Orthosiphon stamineus Extract as New Candidate for Angiotensin I-Converting Enzyme Inhibition: A Molecular Docking Study
title_full_unstemmed Flavonoids-Rich Orthosiphon stamineus Extract as New Candidate for Angiotensin I-Converting Enzyme Inhibition: A Molecular Docking Study
title_sort flavonoids-rich orthosiphon stamineus extract as new candidate for angiotensin i-converting enzyme inhibition: a molecular docking study
publisher MDPI AG
series Molecules
issn 1420-3049
publishDate 2016-11-01
description This study aims to evaluate the in vitro angiotensin-converting enzyme (ACE) inhibition activity of different extracts of Orthosiphon stamineus (OS) leaves and their main flavonoids, namely rosmarinic acid (RA), sinensetin (SIN), eupatorin (EUP) and 3′-hydroxy-5,6,7,4′-tetramethoxyflavone (TMF). Furthermore, to identify possible mechanisms of action based on structure–activity relationships and molecular docking. The in vitro ACE inhibition activity relied on determining hippuric acid (HA) formation from ACE-specific substrate (hippuryl-histidyl-leucine (HHL)) by the action of ACE enzyme. A High Performance Liquid Chromatography method combined with UV detection was developed and validated for measurement the concentration of produced HA. The chelation ability of OS extract and its reference compounds was evaluated by tetramethylmurexide reagent. Furthermore, molecular docking study was performed by LeadIT-FlexX: BioSolveIT’s LeadIT program. OS ethanolic extract (OS-E) exhibited highest inhibition and lowest IC50 value (45.77 ± 1.17 µg/mL) against ACE compared to the other extracts. Among the tested reference compounds, EUP with IC50 15.35 ± 4.49 µg/mL had highest inhibition against ACE and binding ability with Zn (II) (56.03% ± 1.26%) compared to RA, TMF and SIN. Molecular docking studies also confirmed that flavonoids inhibit ACE via interaction with the zinc ion and this interaction is stabilized by other interactions with amino acids in the active site. In this study, we have demonstrated that changes in flavonoids active core affect their capacity to inhibit ACE. Moreover, we showed that ACE inhibition activity of flavonoids compounds is directly related to their ability to bind with zinc ion in the active site of ACE enzyme. It was also revealed that OS extract contained high amount of flavonoids other than RA, TMF, SIN and EUP. As such, application of OS extract is useful as inhibitors of ACE.
topic angiotensin-converting enzyme
hypertension
flavonoids
HPLC-UV
molecular ducking study
url http://www.mdpi.com/1420-3049/21/11/1500
work_keys_str_mv AT armaghanshafaei flavonoidsrichorthosiphonstamineusextractasnewcandidateforangiotensiniconvertingenzymeinhibitionamoleculardockingstudy
AT mdshamsuddinsultankhan flavonoidsrichorthosiphonstamineusextractasnewcandidateforangiotensiniconvertingenzymeinhibitionamoleculardockingstudy
AT abdalrahimfaaisha flavonoidsrichorthosiphonstamineusextractasnewcandidateforangiotensiniconvertingenzymeinhibitionamoleculardockingstudy
AT aminmalikshahabdulmajid flavonoidsrichorthosiphonstamineusextractasnewcandidateforangiotensiniconvertingenzymeinhibitionamoleculardockingstudy
AT mohammadrazakhamdan flavonoidsrichorthosiphonstamineusextractasnewcandidateforangiotensiniconvertingenzymeinhibitionamoleculardockingstudy
AT mohdnizammordi flavonoidsrichorthosiphonstamineusextractasnewcandidateforangiotensiniconvertingenzymeinhibitionamoleculardockingstudy
AT zhariismail flavonoidsrichorthosiphonstamineusextractasnewcandidateforangiotensiniconvertingenzymeinhibitionamoleculardockingstudy
_version_ 1725747503231401984